Literature DB >> 1885230

Adenosine attenuates the response to sympathetic stimuli in humans.

P Smits1, J W Lenders, J J Willemsen, T Thien.   

Abstract

The effect of adenosine on the forearm vasoconstrictor response to alpha-adrenergic and sympathetic stimulation was studied in healthy volunteers. During a predilated state achieved by infusion of sodium nitroprusside into the branchial artery, subsequent infusion of norepinephrine induced a mean increase in forearm vascular resistance of 571%, whereas this response was only 270% when an equipotent vasodilator dose of adenosine was used instead of sodium nitroprusside (nitroprusside versus adenosine, p less than 0.05, n = 6). A comparable difference was found when the endogenous release of norepinephrine was stimulated by the local infusion of tyramine, with tyramine-induced increments in forearm vascular resistance of 438% during nitroprusside versus 93% during adenosine (n = 6, p less than 0.05). During these tyramine infusions a similar increase in the calculated forearm norepinephrine overflow occurred in the adenosine and the nitroprusside tests. In a third experiment, we demonstrated that adenosine also reduced the vasoconstrictor response to lower body negative pressure, an endogenous stimulus, of the sympathetic nervous system. During nitroprusside, lower body negative pressure induced an increase in forearm vascular resistance of 135%, whereas this was 39% during adenosine (n = 6, p less than 0.05). We conclude that adenosine attenuates the response to sympathetic nervous system-mediated vasoconstriction in humans, and that this effect may at least partly be explained by a postsynaptic inhibition of alpha-adrenergic vasoconstriction. Therefore, we think that adenosine may be an important endogenous modulator of sympathetic nervous system activity in humans.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1885230     DOI: 10.1161/01.hyp.18.2.216

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  8 in total

1.  Contribution of adenosine to the depression of sympathetically evoked vasoconstriction induced by systemic hypoxia in the rat.

Authors:  Andrew M Coney; Janice M Marshall
Journal:  J Physiol       Date:  2003-04-17       Impact factor: 5.182

2.  Is sympathetic neural vasoconstriction blunted in the vascular bed of exercising human muscle?

Authors:  Michael E Tschakovsky; Kittiphong Sujirattanawimol; Stephen B Ruble; Zoran Valic; Michael J Joyner
Journal:  J Physiol       Date:  2002-06-01       Impact factor: 5.182

3.  Insulin resistance and vasodilation in essential hypertension. Studies with adenosine.

Authors:  A Natali; R Bonadonna; D Santoro; A Q Galvan; S Baldi; S Frascerra; C Palombo; S Ghione; E Ferrannini
Journal:  J Clin Invest       Date:  1994-10       Impact factor: 14.808

Review 4.  Sulphonylurea treatment of NIDDM patients with cardiovascular disease: a mixed blessing?

Authors:  G Leibowitz; E Cerasi
Journal:  Diabetologia       Date:  1996-05       Impact factor: 10.122

5.  Airway Exposure to Modified Multi-walled Carbon Nanotubes Perturbs Cardiovascular Adenosinergic Signaling in Mice.

Authors:  Leslie C Thompson; Nicole L Sheehan; Dianne M Walters; Robert M Lust; Jared M Brown; Christopher J Wingard
Journal:  Cardiovasc Toxicol       Date:  2019-04       Impact factor: 3.231

6.  Dipyridamole enhances ischaemia-induced reactive hyperaemia by increased adenosine receptor stimulation.

Authors:  P Meijer; C W Wouters; P H H van den Broek; G J Scheffer; N P Riksen; P Smits; G A Rongen
Journal:  Br J Pharmacol       Date:  2008-02-11       Impact factor: 8.739

7.  Hemodynamic and neurohumoral effects of various grades of selective adenosine transport inhibition in humans. Implications for its future role in cardioprotection.

Authors:  G A Rongen; P Smits; K Ver Donck; J J Willemsen; R A De Abreu; H Van Belle; T Thien
Journal:  J Clin Invest       Date:  1995-02       Impact factor: 14.808

Review 8.  Cardiovascular effects of sulphonylurea derivatives. Implications for the treatment of NIDDM?

Authors:  P Smits; T Thien
Journal:  Diabetologia       Date:  1995-01       Impact factor: 10.122

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.